Inventor
RAWLINGS DAVID J
US12 patents
⚠️ This page may combine multiple inventors who share the name “RAWLINGS DAVID J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SEATTLE CHILDRENS HOSPITAL
10 patentsUS11713459B2Aug 1, 2023
Expression of FOXP3 in edited CD34+ cells
SEATTLE CHILDRENS HOSPITAL2 citations65
US11712454B2Aug 1, 2023
Method for treating autoimmune disease using CD4 T-cells with engineered stabilization of expression of endogenous FOXP3 gene
SEATTLE CHILDRENS HOSPITAL0 citations58
US12595492B2Apr 7, 2026
Rapamycin resistant cells
SEATTLE CHILDRENS HOSPITAL0 citations56
US11987804B2May 21, 2024
Rapamycin resistant cells
SEATTLE CHILDRENS HOSPITAL1 citations56
US12385070B2Aug 12, 2025
Homology directed repair compositions for the treatment of hemoglobinopathies
SEATTLE CHILDRENS HOSPITAL0 citations55
US12110499B2Oct 8, 2024
Homology directed repair compositions for the treatment of hemoglobinopathies
SEATTLE CHILDRENS HOSPITAL0 citations55
US11643671B2May 9, 2023
Therapeutic genome editing in Wiskott-Aldrich syndrome and X-linked thrombocytopenia
SEATTLE CHILDRENS HOSPITAL0 citations52
US12433960B2Oct 7, 2025
Vivo gene therapy using intraosseous delivery of a lentiviralgene construct
SEATTLE CHILDRENS HOSPITAL0 citations44
US10494422B2Dec 3, 2019
CCR5 disruption of cells expressing anti-HIV chimeric antigen receptor (CAR) derived from broadly neutralizing antibodies
SEATTLE CHILDRENS HOSPITAL0 citations42
US11939594B2Mar 26, 2024
Engraftable cell-based immunotherapy for long-term delivery of therapeutic proteins
SEATTLE CHILDRENS HOSPITAL0 citations40